Dozens of medical organizations and patient advocacy groups are pushing back against so-called “right-to-try” legislation that passed the Senate in August and is now under consideration in the House. An open letter sent today to House leaders is the latest opposition to the Republican-led push to give desperate patients access to experimental drugs without FDA oversight. President Donald Trump urged passage of a right-to-try bill in his State of the Union speech.
“Our organizations support patient access to unapproved therapies,” the letter reads, in part. “However, the right-to-try bills currently under consideration in the House do not effectuate policy changes that… Read more »
UNDERWRITERS AND PARTNERS